Daniel Rodier

SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission

R. Steinberg, P Brun, Marie Fournier et al. · Neuroscience · 1994 · 84 citations

Neurotensin-induced Behaviour, Molecular Pharmacology, Hypertension +12

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1 S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization

Danielle Gully, Michel Geslin, Laurence Serva et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 75 citations · Full text

Pharmacological Characterization of Tachykinin Receptors Controlling Acetylcholine Release from Rat Striatum: An In Vivo Microdialysis Study

R. Steinberg, Daniel Rodier, J. Souilhac et al. · Journal of Neurochemistry · 1995 · 59 citations

Pharmacological Characterization, Anesthetic Mechanism, Pharmacotherapy +19

Expression and presence of septal neurokinin‐2 receptors controlling hippocampal acetylcholine release during sensory stimulation in rat

R. Steinberg, N. Marco, B. Voutsinos et al. · European Journal of Neuroscience · 1998 · 39 citations

Synaptic Transmission, Neurotransmitter, Sensory Stimulation +21

Facilitation of striatal acetylcholine release by dopamine D1 receptor stimulation: involvement of enhanced nitric oxide production via neurokinin-2 receptor activation

R. Steinberg, J. Souilhac, Daniel Rodier et al. · Neuroscience · 1998 · 32 citations

Striatal Acetylcholine Release, Neurophysiology, Physiology +12